Viewing data from:

ZELNORM

NDA

TEGASEROD MALEATE | N021200 | ALFASIGMA USA INC

2 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ALEMBIC PHARMACEUTICALS LTDTEGASEROD MALEATE

DMF 353672020

BIOPHORE INDIA PHARMACEUTICALS PVT LTDTEGASEROD MALEATE

DMF 370102022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

10 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 2MG BASE

RLD

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 24, 2002

No patent or exclusivity listings for this strength.

#002 — EQ 6MG BASE

RLD

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 24, 2002